Jabs for 5-to-11-year-olds — Pfizer-BioNTech to seek approval by ′mid-October′ | Science | In-depth reporting on science and technology | DW | 10.09.2021

Visit the new DW website

Take a look at the beta version of dw.com. We're not done yet! Your opinion can help us make it better.

  1. Inhalt
  2. Navigation
  3. Weitere Inhalte
  4. Metanavigation
  5. Suche
  6. Choose from 30 Languages

Science

Jabs for 5-to-11-year-olds — Pfizer-BioNTech to seek approval by 'mid-October'

BioNTech's co-founders have said that an application to vaccinate 5-to-11-year-olds will be submitted to health agencies around the world "in the coming weeks" — and that the data from those trials "looks good." In the same interview with Der Spiegel, the CEO of BioNTech said Germany has "60 days to avoid a harsh winter."

Listen to audio 02:58